Professor & Head
Farida Sohrabji’s research program focuses on brain-immune interactions regulated by estrogen and its implications for neuro-inflammatory diseases such as stroke in women. She is also interested in estrogen's interactions with other endogenous and environmental endocrine mediators, including Vitamin D hormone and the peptide hormone Insulin-like Growth Factor (IGF)-1. Her current studies use an animal model to examine age and sex differences in recovery from stroke, focusing at the cellular level on the endothelium and astrocytes, which are the principal components of the blood brain barrier. At the molecular level, she and her team are examining sex and age differences in miRNA and epigenetic markers, with a view to developing biomarkers for diseases and uncovering new therapeutic targets. She is the Joseph Shelton Professor of Neuroscience and associate department chair of the Department of Neuroscience and Experimental Therapeutics in the College of Medicine. Sohrabji also serves as the director of the Women's Health in Neuroscience Program at the College of Medicine and on the steering committee of the Texas Alzheimer's Research and Care Consortium. She also participates in graduate training as a member of the faculty in the Interdisciplinary Program in Neuroscience. Sohrabji earned a joint doctoral degree in neurobiology & biopsychology from the University of Rochester and completed postdoctoral training at Columbia University, College of Physicians and Surgeons, New York. She joined the faculty of Texas A&M College of Medicine in 1998.
Areas of Expertise
Texas A&M in the News
Test To Detect Preeclampsia Earlier In Pregnancy In Development At Texas A&M
New Technology Shows Promise For Safer Cancer Therapy
What Is Ozempic? Texas A&M Pharmacists Explain Drug Viral On Social Media